AI-BOOST AFFINITY
Dead / Abandoned — International registration dead — extension of protection cancelled (as of 26 Sept 2025)
What this means for you
This application is over — abandoned 26 Sept 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79414786
- Mark type
- Stylized text
- Filed
- 04 Oct 2024
- Abandoned
- 26 Sept 2025
Goods and services
- Class 009 — Scientific and electric apparatus: Computer software used in the context of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; computer software used in the context of antibody discovery and identification; artificial intelligence software used in the context of drug discovery, affinity maturation, engineering of biological products, studies of molecular interactions, humanization and identification, drug research, antibody research and design, pharmaceutical research; machine learning software used in the context of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; downloadable software for research, diagnostics, genomics, proteomics, omics and biological products; big data generating software.
- Class 042 — Scientific and technological services: Software as a service [SaaS] for a use in the field of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; medicine discovery services; biological research; scientific services and research in the field of drug discovery, affinity maturation, biological product engineering, studies of molecular interactions, humanization and identification, drug research, antibody, protein, peptide, biological and chemical research and design, pharmaceutical research; antibody sequencing; Research and development services related to AI in the field of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; research and development in the field of drug discovery and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals; research and development services in the field of antibody technology; electronic data storage; Software as a Service [SaaS] including software for machine learning.
Owner
- ProteoGenix, FR
Prosecution history
- 10 Oct 2025 — DEATH OF INTERNATIONAL REGISTRATION
- 13 Jun 2025 — REFUSAL PROCESSED BY IB
- 24 May 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 24 May 2025 — REFUSAL PROCESSED BY MPU
- 27 Mar 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 26 Mar 2025 — NON-FINAL ACTION WRITTEN
- 20 Mar 2025 — ASSIGNED TO EXAMINER
- 17 Jan 2025 — APPLICATION FILING RECEIPT MAILED
- 16 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 Jan 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB